Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Preparation method for rocuronium bromide key intermediate 2alpha, 3alpha-epoxy-16beta-(1-pyrrolidyl)-5alpha- androstane-17 hydroxy

A technology of pyrrolidinyl and rocuronium bromide, applied in the direction of steroids and organic chemistry, can solve the problems of difficult separation of isomers, small steric hindrance, poor stereoselectivity of synthetic routes, etc., and achieve high yield High, low raw material cost, strong stereoselective effect

Inactive Publication Date: 2012-08-15
LIANYUNGANG GUIKE PHARMA
View PDF10 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0021] According to the synthesis method of the existing literature, 2α, 3α-epoxy-16α-bromo-5α-androstan-17 ketone was transformed into 2α, 3α-epoxy-16β-(1-pyrrolidinyl)-5α-androstan-17 In the process of sterane-17 ketone, 2α, 3α-epoxy-16α-bromo-5α-androstan-17 ketone has little steric hindrance due to the carbonyl group at the 17th position, and Br can be substituted from sterane The up and down attack of the body ring, so it is easy to form two isomers of α and β, which will lead to the generation of isomers when the tetrahydropyrrole is substituted in the next step, and the separation of the resulting isomers is more difficult
Therefore, the stereoselectivity of the synthetic route reported in the above-mentioned patent literature is relatively poor

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method for rocuronium bromide key intermediate 2alpha, 3alpha-epoxy-16beta-(1-pyrrolidyl)-5alpha- androstane-17 hydroxy
  • Preparation method for rocuronium bromide key intermediate 2alpha, 3alpha-epoxy-16beta-(1-pyrrolidyl)-5alpha- androstane-17 hydroxy
  • Preparation method for rocuronium bromide key intermediate 2alpha, 3alpha-epoxy-16beta-(1-pyrrolidyl)-5alpha- androstane-17 hydroxy

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0054] Example 1, a key intermediate 2α,3α-epoxy-16β-(1-pyrrolidinyl)-5α-androstane- The preparation method of 17 hydroxyl groups, its synthetic steps are as follows:

[0055] (1) Using the compound 5α-androst-2-en-17one of the formula (II) as a raw material, transesterification with an enene to generate the compound 2,16-diene-17-acetyl oxide of the formula (III); the The enyl ester is selected from any one of vinyl acetate, ethylene carbonate, isopropenyl acetate, phenylpropenyl acetate, tricyclodecenyl propionate or tricyclodecenyl acetate or a mixture of any of several in any proportion ;

[0056] (2) Formula (Ⅲ) compound 2,16-diene-17-acetyl oxide is oxidized by organic peroxyacid to prepare formula (Ⅳ) 2α, 3α, 16α, 17α-diepoxide; the organic peroxy The acid is selected from the group consisting of peroxyformic acid, peroxyacetic acid, peroxytrifluoroacetic acid, peroxypropionic acid, peroxybutyric acid, peroxyisovaleric acid, long chain peroxy fatty acid, peroxybenzoic...

Embodiment 2

[0058] Embodiment 2, the concrete steps of the preparation method described in embodiment 1 are as follows:

[0059] (1) Transesterification reaction: Mix and stir 5α-androst-2-en-17one and enester, heat up to 45°C, slowly add enester solution dissolved in catalyst p-toluenesulfonic acid, dropwise, Warm up the system to reflux state within 3 hours, start slow vacuum distillation after reflux; evaporate the solvent enester to dryness within 6 hours, add ice water to the concentrated solution and stir, immediately a solid precipitates, suction filter and wash the filter with 5°C pure water Cake until neutral; dissolve the precipitated solid in ether, wash the organic phase with water to pH 6.8, combine the organic layer, add anhydrous sodium sulfate or magnesium sulfate to dry for 2.5 hours, filter with suction, add basic alumina to the filtrate, and stir at room temperature After 2h, suction filtration, the filtrate was concentrated, and a light yellow oily substance appeared, ...

Embodiment 3

[0062] Embodiment 3, the concrete steps of the preparation method described in embodiment 1 are as follows:

[0063] (1) Transesterification reaction: Mix and stir 5α-androst-2-en-17one and enester, heat up to 30°C, slowly add enester solution dissolved in catalyst p-toluenesulfonic acid, dropwise, Warm up the system to reflux within 1 hour, start slow vacuum distillation after reflux; evaporate the solvent enester to dryness within 5 hours, add ice water to the concentrated solution and stir, immediately a solid precipitates out, filter with suction and wash with pure water at 0°C Cake until neutral; dissolve the precipitated solid in ether, wash the organic phase with water to pH 7.2, combine the organic layer, add anhydrous sodium sulfate or magnesium sulfate to dry for 2 h, filter with suction, add basic alumina to the filtrate, and stir at room temperature for 1 h , filtered with suction, the filtrate was concentrated, and a light yellow oily substance appeared, and a lar...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of pharmaceutical chemistry synthesis, and relates to a preparation method for a key intermediate 2alpha, 3alpha-epoxy-16beta-(1-pyrrolidyl)-5alpha- androstane-17 hydroxy of rocuronium bromide of steroid muscle relaxant, which includes the steps: leading inexpensive and available 5alpha-androstane-2-alkene-17 ketone and isopropenyl acetate to undergo ester exchange to generate cresyl violet acetate, oxidizing the cresyl violet acetate by the meta-chloroperoxybenzoic acid to obtain an epoxy compound, carrying out an open-loop substitution reaction between the meta-chloroperoxybenzoic acid and pyrrolidine under the alkaline condition, and reducing via sodium borohydride so that the rocuronium bromide key intermediate 2alpha, 3alpha-epoxy-16beta-(1-pyrrolidyl)-5alpha-androstane-17 hydroxy is prepared. An ester group with large steric hindrance is generated at the 17th position when the 5alpha-androstane-2-alkene-17 ketone and the isopropenyl acetate undergo ester exchange in the process to lead stereoscopic steric hindrance of a whole steroid ring to be large, so that attack on the lower portion of the steroid ring can be performed when epoxidation is carried out, and further stereoselectivity is high when an epoxide is formed, and then a beta configuration can be directly formed when the pyrrolidine is used for substitution. The synthesis method is good in stereoselectivity.

Description

technical field [0001] The invention relates to the technical field of organic chemistry and medicinal chemistry, in particular to the key intermediate 2α, 3α-epoxy-16β-(1-pyrrolidinyl)-5α-androstane-17 of steroidal muscle relaxant rocuronium bromide Preparation of Hydroxyl (I). Background technique [0002] Rocuronium bromide, its chemical name is: 1-[(2β,3α,5α,16β,17β)-17-(acetyloxy)-3-hydroxy-2-(4-morpholinyl)androstane- 16-yl]-1-(2-propenyl)pyrrolidinium bromide is a steroidal non-depolarizing muscle relaxant developed by Oknon, the Netherlands. Rocuronium bromide is characterized by rapid onset of action, can provide similar intubation conditions as succinylcholine, its dissociation constant is 0.71±0.09 μM, and its inhibitory effect on motor nerve terminals is similar to that of vecuronium bromide. More importantly, intravenous anesthetics do not affect the neuromuscular blocking effect of this product, and have no effect on the course of action. The strength of thi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07J71/00
Inventor 孔阳夏峰峰刘志
Owner LIANYUNGANG GUIKE PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products